Organometallics
Article
solid (60 mg, 15%). Mp: 210−215 °C. 1H NMR (CDCl3, 500.1
MHz): δ 2.00 (s, 3H, NCCH3), 2.10 (s, 3H, OCCH3), 3.83 (s, 3H,
NCH3), 5.10 (d, J = 2.3 Hz, 1H, CH), 6.72 (d, J = 2.1 Hz, 1H,
NCHCHNCH3), 6.85 (d, J = 8.2 Hz, 1H, CHarom), 7.00 (dd, J1 = 2.3
Hz, J2 = 8.2 Hz, 1H, CHarom), 7.15 (d, J = 2.1 Hz, 1H,
NCHCHNCH3), 7.68 (s, 1H, PtNH), 7.91 (dt, JH,H = 2.3 Hz, JH,Pt
= 24.0 Hz, 1H, PtCCHarom). 13C NMR (CDCl3, 125.8 MHz): δ 27.1
(OCCH3), 28.8 (NCCH3), 35.9 (NCH3), 98.3 (CH), 110.6
(NCCHarom), 114.1 (NCHCHNCH3), 121.3 (NCHCHNCH3),
122.6 (ClCCHarom), 129.7 (NCarom), 131.1 (PtCCHarom), 138.9
(PtCarom), 145.2 (ClCarom), 150.9 (NCN), 163.4 (NCCH3), 177.3
(OCCH3). Anal. Calcd for C15H16ClN3OPt: C, 37.16; H, 3.33; N,
8.67. Found: C, 37.06; H, 3.04; N, 8.83.
procedure described above. Isomer b was obtained as an orange solid
(35 mg, 8.5%). Dec pt: >230 °C. H NMR (CDCl3, 500.1 MHz): δ
1
2.06 (s, 3H, NCCH3), 2.17 (s, 3H, OCCH3), 3.90 (s, 3H, NCH3), 5.17
(d, J = 2.2 Hz, 1H, CH), 6.83 (d, J = 2.1 Hz, 1H, NCHCHNCH3),
7.01 (d, J = 8.5 Hz, 1H, CHarom), 7.27 (s, 1H, NCHCHNCH3), 7.71
(s, 1H, PtNH), 7.96 (dd, J1 = 2.5 Hz, J2 = 8.5 Hz, 1H, CHarom), 8.84
(dt, JH,H = 2.5 Hz, JH,Pt = 24.2 Hz, 1H, PtCCHarom). 13C NMR
(CDCl3, 125.8 MHz): δ 27.1 (OCCH3), 28.9 (NCCH3), 36.1
(NCH3), 98.5 (CH), 109.5 (NCCHarom), 114.6 (NCHCHNCH3),
120.1 (O2NCCHarom), 122.2 (NCHCHNCH3), 126.3 (PtCCHarom),
138.5 (NCarom), 144.5 (PtCarom), 152.8 (NCN), 164.5 (NCCH3),
177.8 (OCCH3). Anal. Calcd for C15H16N4O3Pt·0.2CH2Cl2: C, 35.63;
H, 3.23; N, 10.93. Found: C, 35.95; H, 2.74; N, 10.87.
(SP-4-4)-(4-Aminopent-3-en-2-one-κN,κO)[1-(4-methoxyphenyl)-
3-methylimidazol-2-ylidene-κC,κC′]platinum(II) (20a). A 253 mg
(0.8 mmol) portion of 1-(4-methoxyphenyl)-3-methylimidazolium
iodide and 317 mg of 4-amino-3-penten-2-one were reacted, following
the general procedure described above. Isomer a was obtained as a
(SP-4-4)-(4-Aminopent-3-en-2-one-κN,κO)[1-(4-bromophenyl)-3-
methylimidazol-2-ylidene-κC,κC′]platinum(II) (18a). A 292 mg (0.8
mmol) portion of 1-(4-bromophenyl)-3-methylimidazolium iodide
and 317 mg of 4-amino-3-penten-2-one were reacted, following the
general procedure described above. Isomer a was obtained as a light
1
1
yellow solid (148 mg, 37%). Mp: 171−173 °C. H NMR (CDCl3,
orange solid (172 mg, 41%). Mp: 208−211 °C. H NMR (CDCl3,
500.1 MHz): δ 1.95 (s, 3H, OCCH3), 2.02 (s, 3H, NCCH3), 3.81 (s,
3H, OCH3), 4.09 (s, 3H, NCH3), 5.06 (d, J = 2.3 Hz, 1H, CH), 6.53
(dd, J1 = 2.6 Hz, J2 = 8.4 Hz, 1H, CHarom), 6.74 (d, J = 2.0 Hz, 1H,
NCHCHNCH3), 6.87 (dt, JH,H = 3.5 Hz, JH,Pt = 31.3 Hz, 1H,
PtCCHarom), 6.89 (d, J = 6.7 Hz, 1H, CHarom), 7.14 (d, J = 2.0 Hz, 1H,
NCHCHNCH3), 7.48 (s, 1H, PtNH). 13C NMR (CDCl3, 125.8
MHz): δ 26.9 (OCCH3), 28.2 (NCCH3), 34.6 (NCH3), 55.5 (OCH3),
98.2 (CH), 105.7 (OCCHarom), 110.7 (NCCHarom), 113.8
(NCHCHNCH3), 116.9 (PtCCHarom), 120.9 (NCHCHNCH3),
125.5 (NCarom), 141.9 (PtCarom), 155.8 (CaromOCH3), 160.6 (NCN),
163.1 (NCCH3), 176.8 (OCCH3). Anal. Calcd for C16H19N3O2Pt·
0.2CH2Cl2: C, 39.12; H, 3.93; N, 8.45. Found: C, 39.43; H, 3.52; N,
8.26.
500.1 MHz): δ 1.97 (s, 3H, OCCH3), 2.09 (s, 3H, NCCH3), 4.14 (s,
3H, NCH3), 5.10 (d, J = 2.3 Hz, 1H, CH), 6.81 (d, J = 2.1 Hz, 1H,
NCHCHNCH3), 6.85 (d, J = 8.2 Hz, 1H, CHarom), 7.16 (dd, J1 = 2.0
Hz, J2 = 8.2 Hz, 1H, CHarom), 7.19 (d, J = 2.1 Hz, 1H,
NCHCHNCH3), 7.39 (dt, JH,H = 2.0 Hz, JH,Pt = 30.3 Hz, 1H,
PtCCHarom), 7.44 (s, 1H, PtNH). 13C NMR (CDCl3, 125.8 MHz): δ
26.9 (OCCH3), 28.3 (NCCH3), 34.7 (NCH3), 98.4 (CH), 111.9
(NCCHarom), 113.9 (NCHCHNCH3), 117.1 (NCarom), 121.4
(NCHCHNCH3), 125.5 (BrCCHarom), 127.1 (PtCarom), 132.0
(PtCCHarom), 146.8 (BrCarom), 161.4 (NCN), 163.5 (NCCH3),
176.8 (OCCH3). Anal. Calcd for C15H16BrN3OPt: C, 34.04; H,
3.05; N, 7.94. Found: C, 34.35; H, 3.35; N, 7.64.
(SP-4-3)-(4-Aminopent-3-en-2-one-κN,κO)[1-(4-bromophenyl)-3-
methylimidazol-2-ylidene-κC,κC′]platinum(II) (18b). A 292 mg (0.8
mmol) portion of 1-(4-bromophenyl)-3-methylimidazolium iodide
and 317 mg of 4-amino-3-penten-2-one were reacted, following the
general procedure described above. Isomer b was obtained as a light
(SP-4-3)-(4-Aminopent-3-en-2-one-κN,κO)[1-(4-methoxyphenyl)-
3-methylimidazol-2-ylidene-κC,κC′]platinum(II) (20b). A 253 mg
(0.8 mmol) portion of 1-(4-methoxyphenyl)-3-methylimidazolium
iodide and 317 mg of 4-amino-3-penten-2-one were reacted, following
the general procedure described above. Isomer b was obtained as a
yellow solid (63 mg, 16%). Mp: 185−188 °C. 1H NMR (CDCl3, 500.1
MHz): δ 1.99 (s, 3H, NCCH3), 2.08 (s, 3H, OCCH3), 3.83 (s, 3H,
NCH3), 3.87 (s, 3H, OCH3), 5.09 (d, J = 2.1 Hz, 1H, CH), 6.57 (dd,
J1 = 2.7 Hz, J2 = 8.4 Hz, 1H, CHarom), 6.70 (d, J = 2.0 Hz, 1H,
NCHCHNCH3), 6.87 (d, J = 8.3 Hz, 1H, CHarom), 7.15 (d, J = 2.0 Hz,
1H, NCHCHNCH3), 7.61 (dt, JH,H = 2.7 Hz, JH,Pt = 23.0 Hz, 1H,
PtCCHarom), 7.69 (s, 1H, PtNH). 13C NMR (CDCl3, 125.8 MHz): δ
27.1 (OCCH3), 28.9 (NCCH3), 35.9 (NCH3), 55.4 (OCH3), 98.2
(CH), 108.0 (OCCHa ro m ), 110.2 (NCCHa r o m ), 113.9
(NCHCHNCH3), 116.6 (PtCCHarom), 120.8 (NCHCHNCH3),
138.0 (NCarom), 140.6 (PtCarom), 150.0 (NCN), 156.6 (CaromOCH3),
163.3 (NCCH3), 177.1 (OCCH3). Anal. Calcd for C16H19N3O2Pt·0.2
CH2Cl2: C, 39.12; H, 3.93; N, 8.45. Found: C 39.24, H 3.79; N, 8.15.
(SP-4-4)-(3-Amino-1-phenylbut-2-en-1-one-κN,κO)[1-(4-methox-
yphenyl)-3-methylimidazol-2-ylidene-κC,κC′]platinum(II) (21a). A
253 mg (0.8 mmol) portion of 1-(4-methoxyphenyl)-3-methylimida-
zolium iodide and 516 mg of 3-amino-1-phenyl-2-buten-1-one were
reacted, following the general procedure described above. Isomer a
was obtained as an orange solid (159 mg, 37%). Mp: 207−209 °C. 1H
NMR (CDCl3, 500.1 MHz): δ 2.16 (s, 3H, NCCH3), 3.85 (s, 3H,
OCH3), 4.21 (s, 3H, NCH3), 5.68 (d, J = 2.2 Hz, 1H, CH), 6.57 (dd,
J1 = 2.5 Hz, J2 = 8.4 Hz, 1H, CHarom), 6.80 (d, J = 2.0 Hz, 1H,
NCHCHNCH3), 6.92 (t, JH,Pt = 29.7 Hz, 1H, PtCCHarom), 6.93 (d, J =
10.5 Hz, 1H, NCCHarom), 7.20 (d, J = 2.0 Hz, 1H, NCHCHNCH3),
7.41−7.34 (m, 3H, CHarom), 7.73 (s, 1H, PtNH), 7.83 (dd, J1 = 1.7 Hz,
J2 = 7.8 Hz, 2H, OCCCHarom). 13C NMR (CDCl3, 125.8 MHz): δ 28.8
(NCCH3), 35.1 (NCH3), 55.5 (OCH3), 97.3 (CH), 105.8
(OCCHarom), 110.8 (NCCHarom), 113.8 (NCHCHNCH3), 117.0
(PtCCHarom), 120.9 (NCHCHNCH3), 125.0 (NCarom), 126.6
(CHarom), 128.1 (CHarom), 129.0 (CHarom), 141.8 (PtCarom), 142.1
(OCCarom), 155.8 (CaromOCH3), 160.6 (NCN), 163.9 (NCCH3),
172.7 (OCCarom). Anal. Calcd for C21H21N3O2Pt: C, 46.49; H, 3.90;
N, 7.75. Found: C, 46.36; H, 3.79; N, 7.47.
1
orange solid (61 mg, 14%). Mp: 217−220 °C. H NMR (CDCl3,
500.1 MHz): δ 2.00 (s, 3H, NCCH3), 2.10 (s, 3H, OCCH3), 3.82 (s,
3H, NCH3), 5.10 (d, J = 2.3 Hz, 1H, CH), 6.71 (d, J = 2.1 Hz, 1H,
NCHCHNCH3), 6.80 (d, J = 8.2 Hz, 1H, CHarom), 7.17−7.14 (m, 2H,
NCHCHNCH3, CHarom), 7.67 (s, 1H, PtNH), 8.06 (dt, JH,H = 2.2 Hz,
JH,Pt = 23.8 Hz, 1H, PtCCHarom). 13C NMR (CDCl3, 125.8 MHz): δ
27.2 (OCCH3), 28.8 (NCCH3), 35.9 (NCH3), 98.3 (CH), 111.2
(NCCHarom), 114.1 (NCHCHNCH3), 118.3 (NCarom), 121.3
(NCHCHNCH3), 125.5 (BrCCHarom), 133.9 (PtCCHarom), 139.6
(PtCarom), 145.6 (BrCarom), 151.0 (NCN), 163.4 (NCCH3), 177.3
(OCCH3). Anal. Calcd for C15H16BrN3OPt: C, 34.04; H, 3.05; N,
7.94. Found: C, 33.93; H, 2.87; N, 7.67.
(SP-4-4)-(4-Aminopent-3-en-2-one-κN,κO)[1-(4-nitrophenyl)-3-
methylimidazol-2-ylidene-κC,κC′]platinum(II) (19a). A 265 mg (0.8
mmol) portion of 1-(4-nitrophenyl)-3-methylimidazolium iodide and
317 mg of 4-amino-3-penten-2-one were reacted, following the general
procedure described above. Isomer a was obtained as a red-orange
solid (151 mg, 38%). Dec pt: >275 °C. 1H NMR (CDCl3, 500.1
MHz): δ 2.01 (s, 3H, OCCH3), 2.15 (s, 3H, NCCH3), 4.18 (s, 3H,
NCH3), 5.15 (d, J = 2.3 Hz, 1H, CH), 6.88 (d, J = 2.1 Hz, 1H,
NCHCHNCH3), 7.04 (d, J = 8.6 Hz, 1H, CHarom), 7.29 (d, J = 2.1 Hz,
1H, NCHCHNCH3), 7.55 (s, 1H, PtNH), 7.98 (dd, J1 = 2.3 Hz, J2 =
8.6 Hz, 1H, CHarom), 8.20 (dt, JH,H = 2.3 Hz, JH,Pt = 31.1 Hz, 1H,
PtCCHarom). 13C NMR (CDCl3, 125.8 MHz): δ 26.8 (OCCH3), 28.3
(NCCH3), 34.9 (NCH3), 98.7 (CH), 110.2 (NCCHarom), 114.3
(NCHCHNCH3), 120.1 (O2NCCHarom), 122.4 (NCHCHNCH3),
124.2 (PtCCHarom), 126.1 (NCarom), 143.8 (PtCarom), 153.3
(NO2Carom), 162.9 (NCN), 164.0 (NCCH3), 177.0 (OCCH3). Anal.
Calcd for C15H16N4O3Pt: C, 36.37; H, 3.26; N, 11.31. Found: C,
36.48; H, 3.05; N, 11.01.
(SP-4-3)-(4-Aminopent-3-en-2-one-κN,κO)[1-(4-nitrophenyl)-3-
methylimidazol-2-ylidene-κC,κC′]platinum(II) (19b). A 265 mg (0.8
mmol) portion of 1-(4-nitrophenyl)-3-methylimidazolium iodide and
317 mg of 4-amino-3-penten-2-one were reacted, following the general
906
dx.doi.org/10.1021/om401023f | Organometallics 2014, 33, 898−908